Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
KerusCloudmmsholdings.com · Low evidenceMMS Holdings offers KerusCloud®, a clinical trial design and simulation platform that uses cloud-based technology to model thousands of trial scenarios in silico. The software helps sponsors optimize study designs, reduce risk, and increase the probability of success by up to 41%.
KerusCloudKerusCloudParse Score